Figures & data
Figure 1 Pretreatment 2.5 cm contrast-enhancing mass in the right lower lobe (A). Volumetric modulated arc therapy plan with the planning target volume (B). Dose distribution with isodose lines, from 100% to 30% (C). Complete tumor response 2 months after treatment (D).
